Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
Terns Pharmaceuticals (Nasdaq: TERN) announced that senior management will present at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:30 p.m. GMT.
A live webcast will be available on the company's investor relations site at http://ir.ternspharma.com, and a replay will be archived on the site for at least 30 days after the event.
Terns Pharmaceuticals (Nasdaq: TERN) ha comunicato che i vertici presenteranno alla Jefferies Global Healthcare Conference a Londra il lunedì 17 novembre 2025 alle ore 16:30 GMT.
Una trasmissione webcast in diretta sarà disponibile sul sito investor relations dell'azienda all'indirizzo http://ir.ternspharma.com, e una replica sarà archiviata sul sito per almeno 30 giorni dopo l'evento.
Terns Pharmaceuticals (Nasdaq: TERN) anunció que la alta dirección presentará en la Jefferies Global Healthcare Conference in London en lunes 17 de noviembre de 2025 a las 4:30 p.m. GMT.
Se podrá seguir una transmisión en vivo en el sitio de relaciones con inversores de la empresa en http://ir.ternspharma.com, y una repetición quedará archivada en el sitio durante al menos 30 días después del evento.
Terns Pharmaceuticals (Nasdaq: TERN)은(는) 고위 경영진이 런던에서 열리는 Jefferies Global Healthcare Conference에서 2025년 11월 17일 월요일 오후 4시 30분 GMT에 발표할 것이라고 발표했습니다.
생방송 webcast는 회사의 투자자 관계 사이트 http://ir.ternspharma.com에서 이용 가능하며, 이벤트 종료 후 최소 30일 동안 사이트에 재방송이 보관됩니다.
Terns Pharmaceuticals (Nasdaq: TERN) a annoncé que la direction générale présentera lors de la Jefferies Global Healthcare Conference à Londres le lundi 17 novembre 2025 à 16h30 GMT.
Une webdiffusion en direct sera disponible sur le site des relations investisseurs de l'entreprise à l'adresse http://ir.ternspharma.com, et une rediffusion sera archivée sur le site pendant au moins 30 jours après l'événement.
Terns Pharmaceuticals (Nasdaq: TERN) kündigte an, dass das Top-Management auf der Jefferies Global Healthcare Conference in London am Montag, den 17. November 2025 um 16:30 GMT auftreten wird.
Eine Live-Webcast wird auf der Investor-Relations-Webseite des Unternehmens unter http://ir.ternspharma.com verfügbar sein, und eine Wiederholung wird dort für mindestens 30 Tage nach dem Ereignis archiviert.
Terns Pharmaceuticals (Nasdaq: TERN) أعلنت أن الإدارة العليا ستقدم في مؤتمر الرعاية الصحية العالمي جيفريز في لندن في يوم الإثنين 17 نوفمبر 2025 الساعة 4:30 مساءً بتوقيت GMT.
ستتوفر بث حي على موقع علاقات المستثمرين للشركة على http://ir.ternspharma.com، وسيُArشَفة إعادة العرض على الموقع لمدة لا تقل عن 30 يوماً بعد الحدث.
- None.
- None.
FOSTER CITY, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be presenting at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:30 p.m. GMT.
A live webcast of the presentation will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcast will be archived on Terns’ website for at least 30 days following the event.
About Terns Pharmaceuticals
Terns Pharmaceuticals is a clinical-stage oncology company reimagining known biology to deliver high impact medicines. Our lead program TERN-701 is a highly selective, allosteric BCR-ABL inhibitor with a potentially best-in-disease profile that could meaningfully improve upon the efficacy, safety and convenience of existing treatments for CML. For more information, please visit: www.ternspharma.com.
Contacts for Terns
Investors
Justin Ng
investors@ternspharma.com
Media
Jenna Urban
CG Life
media@ternspharma.com